A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations

Journal of Perinatology

Volumn 20, Issue 7, 2000, Pages 408-413

  Lam, Fung ^a   Bergauer, Niki K ^b   Coleman, Suzanne K ^b   Stanziano, Gary J ^b   Jacques, Debbie ^b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b Matria Healthcarem Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; INFUSION PUMP; ORAL DRUG ADMINISTRATION; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; RETROSPECTIVE STUDY; TIME;

ADMINISTRATION, ORAL; ADULT; COHORT STUDIES; FEMALE; HUMANS; INFUSION PUMPS, IMPLANTABLE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TERBUTALINE; TIME FACTORS; TOCOLYTIC AGENTS;

EID: 0034305175     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200424     Document Type: Article

References (27)

1. Ventura SJ, Martin JA, Curtin SC, Mathews TJ. Report of final natality statistics, 1996. Monthly Vital Statistics Report Vol. 46, No. 11, Supp. Hyattsville, Maryland: National Center for Health Statistics, 1998.
2. Goldenberg RL, Iams JD, Miodovnik M, et al. NICHHDMFMUN. The preterm prediction study, risk factors in twin gestations. Am J Obstet Gynecol 1996; 175:1047-1053.
3. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-agonist ritodrine. N Engl J Med 1992;327:308-312.
4. Chau AC, Gabert HA, Miller JM. A prospective comparison of terbutaline and magnesium for tocolysis. Obstet Gynecol 1992;80:847-851.
5. Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996;175:838-842.
6. How HY, Hughes SA, Vogel RI, Gall SA, Spinnato JA. Oral terbutaline in the outpatient management of preterm labor. Am J Obstet Gynecol 1995;173:1518-1522.
7. Macones GA, Berlin M, Berlin JA. Efficacy of oral beta-agonist maintenance therapy in preterm labor: A meta-analysis. Obstet Gynecol 1995;85:313-317.
8. Lewis R, Mercer BM, Salama M, Walsh MA, Sibai BM. Oral terbutaline after parenteral tocolysis: A randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1996;175:834-837.
9. Copper RL, Goldenberg RL, Creasy RK, et al. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol 1993;168:78-84.
10. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312:82-90.
11. Berg G, Andersson RGG, Ryden G. Beta-adrenergic receptors in human myometrium during pregnancy: Changes in the number of receptors after beta-mimetic treatment. Am J Obstet Gynecol 1985;85:313-317.
12. Wischnik A. Risk-benefit assessment of tocolytic drugs. Drug Saf 1991;6:371-381.
13. Perry KG, Morrison JC, Rust OA, Sullivan CA, Martin RW, Naef RW. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. Am J Obstet Gynecol 1995;173:1273-1277.
14. Lam F, Gill PJ, Smith M, Kitzmiller JL, Katz M. Use of subcutaneous terbutaline pump for long-term tocolysis. Obstet Gynecol 1988;72:810-813.
15. Allbert JR, Wise CA, Lou CH, et al. Subcutaneous tocolytic infusion therapy for patients at high risk for preterm birth. J Perinatal 1992;12:28-31.
16. Adkins RT, Van Hooydonk JE, Bressman PL, et al. Prevention of preterm birth: Early detection and aggressive treatment with terbutaline. South Med J 1993;86:157-164.
17. Omer H, Palti Z, Freidlander D. Evaluating treatments for preterm labor possible solutions for some methodological problems. Eur J Obstet Gynecol Reprod Biol 1986;22:229-236.
18. Wenstrom KD, Weiner CP, Merrill D, Neibyl J. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. J Perinatal 1997;14:87-91.
19. Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. Terbutaline pump maintenance therapy for prevention of preterm delivery: A double-blind trial. Am J Obstet Gynecol 1998;179:874-878.
20. Nageotte MP, Dorchester W, Porto M, Keegan KA Jr, Freeman RK. Quantitation of uterine activity preceding preterm, term, and postterm labor. Am J Obstet Gynecol 1988;156:1254-1259.
21. Katz M, Newman RB, Gill PJ. Assessment of uterine activity in ambulatory patients at risk for preterm labor and delivery. Am J Obstet Gynecol 1986;154:44-47.
22. Garite TJ, Bentley DL, Hamer CA, Porto ML. Uterine activity characteristics in multiple gestations. Obstet Gynecol 1990;76(suppl):56S-59S.
23. Lam F, Bergauer NK, Stanziano GJ, Jacques D. Pregnancy prolongation and route of tocolytic administration inpatients with singleton gestation. Am J Obstet Gynecol 1998;178:180.
24. Allbert JR, Johnson C, Roberts WE, et al. Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump. J Reprod Med 1994;39:614-618.
25. Elliott JP, Flynn MJ, Kaemmerer EL, Radin TG. Terbutaline pump tocolysis in high-order multiple gestation. J Reprod Med 1997;42:687-694.
26. Moise KJ Jr, Sala DJ, Zurawin RK, Cano LE, Hesketh DE, Carpenter RJ. Continuous subcutaneous terbutaline pump for premature labor: Safety and efficacy. South Med J 1992;85:255-260.
27. Moore TR, lams JD, Creasy RK, Burau KD, Davidson AL Diurnal and gestational patterns of uterine activity in normal human pregnancy. Obstet Gynecol 1994;83:517-523.